Cited by 133Neurotransmitter Receptor Influence on BehaviorTreatment of Major DepressionTryptophan and brain disorders

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression

Parsey, Ramin V, Oquendo, Maria A, Zea-Ponce, Yolanda, Rodenhiser, Janine, Kegeles, Lawrence S, Pratap, Mali, Cooper, Thomas B, Van Heertum, Ronald, Mann, J.John, Laruelle, Marc·2001·Biological Psychiatry

DOI 10.1016/s0006-3223(01)01089-7

Open this paper in CoChat — free account

Abstract

Background Reduced dopaminergic transmission has been implicated in the pathophysiology of major depression. The aim of the present study was to measure striatal D(2) receptor availability and amphetamine-induced dopamine release in nonpsychotic, unmedicated, unipolar patients during an episode of major depression.Methods The striatal equilibrium specific to nonspecific partition coefficient (V(3)") of the D(2) receptor antagonist [(123)I]IBZM was measured with single photon emission computerized tomography before and after amphetamine administration in 9 depressed subjects and 10 matched healthy control subjects.Results No significant differences were observed in preamphetamine D(2) receptor availability between depressed patients (0.73 +/- 0.08) and control subjects (0.78 +/- 0.10, p =.23). Amphetamine-induced reduction in [(123)I]IBZM V(3)" (DeltaV(3)") was similar in depressed patients (-9.8 +/- 5.5%) and control subjects (-7.8 +/- 2.5%, p =.32). Amphetamine induced a transient improvement in symptomatology in depressed patients, but this improvement did not correlate with [(123)I]IBZM DeltaV(3)".Conclusions This study did not replicate previously reported alterations in striatal D(2) receptor density in depressed patients and suggests that stimulant-induced dopamine release is not altered in major depression.

Integrity signals

Registry

Crossref · 10.1016/s0006-3223(01)01089-7

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A rating scale for depression
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
The Structured Clinical Interview for DSM-III-R (SCID): I: History, Rationale, and Description
Spitzer, R. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080032005 · Cited by 4,336
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
From motivation to action: Functional interface between the limbic system and the motor system
MOGENSON, G., JONES, D., & YIM, C. (1980) · Progress in Neurobiology · doi:10.1016/0301-0082(80)90018-0 · Cited by 2,331
Negative Symptoms in Schizophrenia: Definition and Reliability
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070020005 · Cited by 2,247
Brain Dopamine and Reward
Wise, R. A., & Rompre, P.-P. (1989) · Annual Review of Psychology · doi:10.1146/annurev.ps.40.020189.001203 · Cited by 1,968
Rapid Automated Algorithm for Aligning and Reslicing PET Images
Woods, R. P., Cherry, S. R., & Mazziotta, J. C. (1992) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199207000-00024 · Cited by 1,901
Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects
Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291
Self-citation
Chronic mild stress-induced anhedonia: A realistic animal model of depression
Willner, P., Muscat, R., & Papp, M. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80194-0 · Cited by 1,160

Show all 50 references

Research works printed but not linked: 2

Laruelle, 1994, Compartmental modeling of iodine-123-iodobenzofuran binding to dopamine D2 receptors in healthy subjects, J Nucl Med, 35, 743
Malison, 1999, Reduced amphetamine-stimulated dopamine release in cocaine addicts as measured by [123I]IBZM SPECT, J Nucl Med, 40, 110P

Sorted by citations

The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
Reconsidering anhedonia in depression: Lessons from translational neuroscience
Treadway, M. T., & Zald, D. H. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.006 · Cited by 1,579
Neuroimaging studies of mood disorders
Drevets, W. C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01020-9 · Cited by 1,334
The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244
Imaging Human Mesolimbic Dopamine Transmission with Positron Emission Tomography. Part II: Amphetamine-Induced Dopamine Release in the Functional Subdivisions of the Striatum
Martinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.-R., Huang, Y., Cooper, T., Kegeles, L., Zarahn, E., Abi-Dargham, A., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000048520.34839.1a · Cited by 569
Self-citation
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 474
Glutamate, Dopamine, and Schizophrenia: From Pathophysiology to Treatment
LARUELLE, M., KEGELES, L. S., & ABI‐DARGHAM, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.063 · Cited by 437
Self-citation
Neurobiology of chronic mild stress: parallels to major depression
Hill, M. N., Hellemans, K. G. C., Verma, P., Gorzalka, B. B., & Weinberg, J. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.07.001 · Cited by 420
Neurobiology of Dopamine in Schizophrenia
Guillin, O., Abi‐Dargham, A., & Laruelle, M. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78001-1 · Cited by 365
Self-citation
Review: Glutamate and dopamine dysregulation in schizophrenia — a synthesis and selective review
Stone, J. M., Morrison, P. D., & Pilowsky, L. S. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106073126 · Cited by 362
Functional Neuroanatomical Substrates of Altered Reward Processing in Major Depressive Disorder Revealed by a Dopaminergic Probe
Tremblay, L. K., Naranjo, C. A., Graham, S. J., Herrmann, N., Mayberg, H. S., Hevenor, S., & Busto, U. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.11.1228 · Cited by 340
Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
Dopamine hypothesis of schizophrenia: Making sense of it all
Toda, M., & Abi-Dargham, A. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0041-7 · Cited by 235
Neurobiology of Chronic Stress-Related Psychiatric Disorders: Evidence from Molecular Imaging Studies
Davis, M. T., Holmes, S. E., Pietrzak, R. H., & Esterlis, I. (2017) · Chronic Stress · doi:10.1177/2470547017710916 · Cited by 194
Dopaminergic-based pharmacotherapies for depression
Papakostas, G. I. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.12.002 · Cited by 171
Dynamics of the dopaminergic system as a key component to the understanding of depression
Yadid, G., & Friedman, A. (2008) · Progress in brain research · doi:10.1016/s0079-6123(08)00913-8 · Cited by 160
Elevated Putamen D 2 Receptor Binding Potential in Major Depression With Motor Retardation: An [ 11 C]Raclopride Positron Emission Tomography Study
Meyer, J. H., McNeely, H. E., Sagrati, S., Boovariwala, A., Martin, K., Verhoeff, N. P. L. G., Wilson, A. A., & Houle, S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1594 · Cited by 160
Dopamine D2-Like Receptors and the Antidepressant Response
Gershon, A. A., Vishne, T. H., & Grunhaus, L. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.031 · Cited by 166
In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐raclopride
Narendran, R., Hwang, D., Slifstein, M., Talbot, P., Erritzoe, D., Huang, Y., Cooper, T. B., Martinez, D., Kegeles, L. S., Abi-Dargham, A., et al. (2004) · Synapse · doi:10.1002/syn.20013 · Cited by 156
Self-citation
Brain Imaging Studies in Mood and Anxiety Disorders
Anand, A., & Shekhar, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07095.x · Cited by 158
Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis
Howes, O. D., Montgomery, A. J., Asselin, M., Murray, R. M., Grasby, P. M., & McGuire, P. K. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.191.51.s13 · Cited by 144
Acute prefrontal rTMS increases striatal dopamine to a similar degree as D-amphetamine
Pogarell, O., Koch, W., Pöpperl, G., Tatsch, K., Jakob, F., Mulert, C., Grossheinrich, N., Rupprecht, R., Möller, H.-J., Hegerl, U., et al. (2007) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.05.002 · Cited by 133
Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide
Abi-Dargham, A., Kegeles, L. S., Zea-Ponce, Y., Mawlawi, O., Martinez, D., Mitropoulou, V., O'Flynn, K., Koenigsberg, H. W., Van Heertum, R., Cooper, T., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.018 · Cited by 128
Self-citation
In vivo imaging of synaptic function in the central nervous system: II. Mental and affective disorders
Nikolaus, S., Antke, C., & Müller, H. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.06.009 · Cited by 128
Is depression associated with dysfunction of the central reward system?
Martin-Söelch, C. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370313 · Cited by 123
Dopamine Type-1 Receptor Binding in Major Depressive Disorder Assessed Using Positron Emission Tomography and [11C]NNC-112
Cannon, D. M., Klaver, J. M., Peck, S. A., Rallis, D., Erickson, K., & Drevets, W. C. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.194 · Cited by 122
Striatal dopamine D2/3 receptor-mediated neurotransmission in major depression: Implications for anhedonia, anxiety and treatment response
Peciña, M., Sikora, M., Avery, E. T., Heffernan, J., Peciña, S., Mickey, B. J., & Zubieta, J.-K. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.08.427 · Cited by 125
Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: a comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride
Seneca, N., Finnema, S. J., Farde, L., Gulyás, B., Wikström, H. V., Halldin, C., & Innis, R. B. (2006) · Synapse · doi:10.1002/syn.20238 · Cited by 110
Psychopathological symptoms in child and adolescent migraine and tension-type headache: A meta-analysis
Balottin, U., Fusar‐Poli, P., Termine, C., Molteni, S., & Galli, F. (2012) · Cephalalgia · doi:10.1177/0333102412468386 · Cited by 105
The subjective and cognitive effects of acute phenylalanine and tyrosine depletion in patients recovered from depression
Roiser, J. P., McLean, A., Ogilvie, A. D., Blackwell, A. D., Bamber, D. J., Goodyer, I., Jones, P. B., & Sahakian, B. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300659 · Cited by 96
NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humans
Kegeles, L. S., Martínez, D., Kochan, L. D., Hwang, D., Huang, Y. H., Mawlawi, O. R., Suckow, R. F., Heertum, R. L. V., & Laruelle, M. A. (2001) · Synapse · doi:10.1002/syn.10010 · Cited by 97
Self-citation
Striatal structure and function in mood disorders: a comprehensive review
Marchand, W. R., & Yurgelun‐Todd, D. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00874.x · Cited by 91
A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey.
Finnema, S., Seneca, N., Farde, L., Shchukin, E., Sóvágó, J., Gulyás, B., Wikström, H., Innis, R., Neumeyer, J., & Halldin, C. (2005) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2005.01.007 · Cited by 86
Correlation of individual differences in schizotypal personality traits with amphetamine-induced dopamine release in striatal and extrastriatal brain regions
Woodward, N. D., Cowan, R. L., Park, S., Ansari, M. S., Baldwin, R. M., Li, R., Doop, M., Kessler, R. M., & Zald, D. H. (2011) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.10020165 · Cited by 90
Influences of dopaminergic system dysfunction on late-life depression
Taylor, W. D., Zald, D. H., Felger, J. C., Christman, S., Claassen, D. O., Horga, G., Miller, J. M., Gifford, K., Rogers, B., Szymkowicz, S. M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-021-01265-0 · Cited by 89
Striatal dopamine in bulimia nervosa: A pet imaging study
Broft, A. I., Shingleton, R. M., Kaufman, J., Liu, F., Kumar, D. J. S., Slifstein, M., Abi‐Dargham, A., Schebendach, J., Heertum, R. V., Attia, E., et al. (2012) · International Journal of Eating Disorders · doi:10.1002/eat.20984 · Cited by 88
Neuropsychiatric Adverse Effects of Amphetamine and Methamphetamine
Harro, J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.02.004 · Cited by 84
A Critique of the Dopamine Hypothesis of Schizophrenia and Psychosis
Moncrieff, J. (2009) · Harvard Review of Psychiatry · doi:10.1080/10673220902979896 · Cited by 83
Effects of repetitive transcranial magnetic stimulation on [11C]raclopride binding and cognitive function in patients with depression
Kuroda, Y., Motohashi, N., Ito, H., Ito, S., Takano, A., Nishikawa, T., & Suhara, T. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.03.029 · Cited by 77
“There have been a few studies that compared BP obtained with [I]iodobenzamide (IBZM) in depressed patients with that in age-matched healthy controls (D'haenen and Bossuyt, 1994; Ebert et al., 1994, 1996; Shah et al., 1997; Klimke et al., 1999; Parsey et al., 2001).”
Result
Imaging the pathophysiology of major depressive disorder - from localist models to circuit-based analysis
Treadway, M. T., & Pizzagalli, D. A. (2014) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-4-5 · Cited by 79
Contributions from brain imaging to the elucidation of pathophysiology of bipolar disorder
Soares, J. C. (2003) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145703003390 · Cited by 75
Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naı̈ve healthy volunteers: results from a large cohort
Abi‐Dargham, A., Kegeles, L. S., Martínez, D., Innis, R. B., & Laruelle, M. A. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.007 · Cited by 72
Self-citation
Dopamine overflow is increased in olfactory bulbectomized rats: an in vivo microdialysis study
Masini, C. V., Holmes, P. V., Freeman, K. G., Maki, A. C., & Edwards, G. L. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.01.003 · Cited by 71
Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET
Hirvonen, J., Karlsson, H., Kajander, J., Markkula, J., Rasi-Hakala, H., Någren, K., Salminen, J. K., & Hietala, J. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1088-9 · Cited by 70
Greater availability of dopamine transporters in patients with major depression — A dual-isotope SPECT study
Yang, Y. K., Yeh, T. L., Yao, W. J., Lee, I. H., Chen, P. S., Chiu, N.-T., & Lu, R. B. (2008) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.08.008 · Cited by 69
Effect of amphetamine on [18F]fallypride in vivo binding to D2 receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies
Slifstein, M., Narendran, R., Hwang, D., Sudo, Y., Talbot, P. S., Huang, Y. H., & Laruelle, M. A. (2004) · Synapse · doi:10.1002/syn.20062 · Cited by 66
Self-citation
Adolescent nicotine exposure induces dysregulation of mesocorticolimbic activity states and depressive and anxiety-like prefrontal cortical molecular phenotypes persisting into adulthood
Jobson, C. L. M., Renard, J., Szkudlarek, H., Rosen, L. G., Pereira, B., Wright, D. J., Rushlow, W., & Laviolette, S. R. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhy179 · Cited by 64
Decreased striatal D1 binding as measured using PET and [11C]SCH 23,390 in patients with major depression with anger attacks
Dougherty, D. D., Bonab, A. A., Ottowitz, W. E., Livni, E., Alpert, N. M., Rauch, S. L., D, M. F. M., & Fischman, A. J. (2006) · Depression and Anxiety · doi:10.1002/da.20168 · Cited by 65
The Neurobiology of Motivational Deficits in Depression—An Update on Candidate Pathomechanisms
Treadway, M. T. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_400 · Cited by 66
WINCS Harmoni: Closed-loop dynamic neurochemical control of therapeutic interventions
Lee, K. H., Luján, J. L., Trevathan, J. K., Ross, E. K., Bartoletta, J. J., Park, H. O., Paek, S. B., Nicolai, E. N., Lee, J. H., Min, H.-K. P., et al. (2017) · Scientific Reports · doi:10.1038/srep46675 · Cited by 64
Striatal dopamine deficits predict reductions in striatal functional connectivity in major depression: a concurrent 11C-raclopride positron emission tomography and functional magnetic resonance imaging investigation
Hamilton, J. P., Sacchet, M. D., Hjørnevik, T., Chin, F. T., Shen, B., Kämpe, R., Park, J. H., Knutson, B. D., Williams, L. M., Borg, N., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0316-2 · Cited by 68
Dopamine receptor gene expression in human amygdaloid nuclei: Elevated D4 receptor mRNA in major depression
Xiang, L., Szebeni, K., Szebeni, A., Klimek, V., Stockmeier, C. A., Karolewicz, B., Kalbfleisch, J. H., & Ordway, G. A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.009 · Cited by 64
Extrastriatal D2 and striatal D2 receptors in depressive illness: Pilot PET studies using [11C]FLB 457 and [11C]raclopride
Montgomery, A. J., Stokes, P. R. A., Kitamura, Y., & Grasby, P. M. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.11.010 · Cited by 59
Reduced striatal D2 receptor binding in myoclonus–dystonia
Beukers, R. J., Booij, J., Weisscher, N., Zijlstra, F., van Amelsvoort, T., & Tijssen, M. A. J. (2008) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-008-0924-9 · Cited by 58
Molecular and neuronal mechanisms underlying the effects of adolescent nicotine exposure on anxiety and mood disorders
Laviolette, S. R. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108411 · Cited by 57
Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression
Rocca, P., Leo, C. D., Eva, C. E., Marchiaro, L., Milani, A. M., Musso, R., Ravizza, L., Zanalda, E., & Bogetto, F. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(02)00253-1 · Cited by 58
Dopamine in major depressive disorder: A systematic review and meta-analysis of in vivo imaging studies
Mizuno, Y., Ashok, A. H., Bhat, B. B., Jauhar, S., & Howes, O. D. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231200881 · Cited by 63
Dopaminergic activity in depressed smokers: A positron emission tomography study
Busto, U. E., Redden, L., Mayberg, H. S., Kapur, S., Houle, S., & Zawertailo, L. A. (2009) · Synapse · doi:10.1002/syn.20646 · Cited by 55
Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants
Mischoulon, D., Hylek, L., Yeung, A., Clain, A. J., Baer, L., Cusin, C., Ionescu, D. F., Alpert, J. E., Soskin, D. P., & D, M. F. M. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.08.029 · Cited by 55
Striatal dopamine type 2 receptor availability in anorexia nervosa
Broft, A. I., Slifstein, M., Osborne, J. R., Kothari, P. J., Morim, S., Shingleton, R. M., Kenney, L., Vallabhajosula, S., Attia, E., Martínez, D., et al. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.06.013 · Cited by 60
Dopamine Transmission in the Schizophrenic Brain
Laruelle, M. A. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch20 · Cited by 53
Self-citation
Neuropathological changes in the substantia nigra in schizophrenia but not depression
Williams, M. R., Galvin, K., OSullivan, B., Macdonald, C., Ching, E. W.-K., Turkheimer, F., Howes, O. D., Pearce, R. K. B., Hirsch, S. R., & Maier, M. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0479-z · Cited by 52
Antidepressant-like and antinociceptive-like actions of 4-(4′-chlorophenyl)-6-(4″-methylphenyl)-2-hydrazinepyrimidine Mannich base in mice
Rodrigues, A. L. S., Rosa, J. M., Gadotti, V. M., Goulart, E. C., Santos, M. M. M., Silva, A., Sehnem, B., Rosa, L. S., Gonçalves, R. M., Corrêa, R., et al. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.08.003 · Cited by 49
A review of the neurobiological underpinning of comorbid substance use and mood disorders
Gómez‐Coronado, N., Sethi, R., Bortolasci, C. C., Arancini, L., Berk, M., & Dodd, S. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.041 · Cited by 53
Postpartum and Depression Status are Associated With Lower [11C]raclopride BPND in Reproductive-Age Women
Moses‐Kolko, E. L., Price, J. C., Wisner, K. L., Hanusa, B. H., MELTZER, C. C., Berga, S. L., Grace, A. A., di Scalea, T. L., Kaye, W. H., Becker, C. R., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.328 · Cited by 49
Translational Research in Late-Life Mood Disorders: Implications for Future Intervention and Prevention Research
Smith, G. S., Gunning‐Dixon, F. M., Lotrich, F. E., Taylor, W. D., & Evans, J. D. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301333 · Cited by 45
Anhedonia in Unipolar Major Depressive Disorder: A Review~!2009-10-26~!2010-02-18~!2010-04-08~!
Dichter, G. S. (2010) · The Open Psychiatry Journal · doi:10.2174/1874354401004010001 · Cited by 53
Acute and Chronic Effects of Citalopram on Cerebral Glucose Metabolism in Geriatric Depression
Smith, G. S., Kramer, E., Hermann, C. R., Goldberg, S., Ma, Y., DHAWAN, V. M., Barnes, A., Chaly, T., Belakhleff, A., Laghrissi‐Thode, F., et al. (2002) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200211000-00010 · Cited by 44
Measuring Dopamine Synaptic Transmission with Molecular Imaging and Pharmacological Challenges: The State of the Art
Laruelle, M. A. (2012) · Neuromethods · doi:10.1007/7657_2012_45 · Cited by 43
Self-citation
Psychiatric disorders and headache familial recurrence: a study on 200 children and their parents
Galli, F., Canzano, L., Scalisi, T. G., & Guidetti, V. (2009) · The Journal of Headache and Pain · doi:10.1007/s10194-009-0105-7 · Cited by 45
Effect of a History of Major Depressive Disorder on Smoking-Induced Dopamine Release
Brody, A. L., Olmstead, R. E., Abrams, A. L., Costello, M. R., Khan, A., Kozman, D. M., Saxena, S., Farahi, J. B., London, E. D., & Mandelkern, M. A. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.011 · Cited by 41
Sunshine-exposure variation of human striatal dopamine D2/D3 receptor availability in healthy volunteers
Tsai, H.-Y., Chen, K. C., Yang, Y. K., Chen, P. S., Yeh, T. L., Chiu, N.-T., & Lee, I. H. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.09.014 · Cited by 43
Recent Advances in the Neurobiology of Depression
Normann, C., & Berger, T. (2003) · CRC Press eBooks · doi:10.3109/9780203002889-3 · Cited by 37
Anhedonia in Unipolar Major Depressive Disorder: A Review
Dichter, G. S. (2010) · The Open Psychiatry Journal · Cited by 36
Dopamine Release in Antidepressant-Naive Major Depressive Disorder: A Multimodal [11C]-(+)-PHNO Positron Emission Tomography and Functional Magnetic Resonance Imaging Study
Schneier, F. R., Slifstein, M., Whitton, A. E., Pizzagalli, D. A., Reinen, J., McGrath, P. J., Iosifescu, D. V., & Abi‐Dargham, A. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.05.014 · Cited by 39
Key players in major and bipolar depression—A retrospective analysis of in vivo imaging studies
Nikolaus, S., Hautzel, H., Heinzel, A., & Müller, H. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.03.021 · Cited by 35
Molecular imaging of striatal dopamine transporters in major depression—A meta-analysis
Li, Z., Hé, Y., Tang, J., Zong, X., Hu, M., & Chen, X. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.11.045 · Cited by 36
Acute anxiety disorder, major depressive disorder, bipolar disorder and schizophrenia are related to different patterns of nigrostriatal and mesolimbic dopamine dysfunction
Nikolaus, S., Mamlins, E., Hautzel, H., & Müller, H.-W. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0037 · Cited by 35
Effects of fluoxetine on dopamine D2 receptors in the human brain: a positron emission tomography study with [11C]raclopride
Penttilä, J., Kajander, J., Aalto, S., Hirvonen, J., Någren, K., Ilonen, T., Syvälahti, E. K. G., & Hietala, J. A. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570400450x · Cited by 32
Positron emission tomography and single photon emission CT molecular imaging in schizophrenia
Erritzøe, D., Talbot, P. S., Frankle, W. G., & Abi‐Dargham, A. (2003) · Neuroimaging Clinics of North America · doi:10.1016/s1052-5149(03)00089-3 · Cited by 31
Recent advances in the neurobiology of depression
Normann, C., & Berger, T. (2003) · CRC Press eBooks · doi:10.3109/9780203002889-5 · Cited by 30
The emerging biology of delusions
Murray, G. (2010) · Psychological Medicine · doi:10.1017/s0033291710000413 · Cited by 29
Neuroimaging and Neuropathological Studies of Mood Disorders
Drevets, W. C., & Price, J. L. (2005) · Biology of Depression · doi:10.1002/9783527619672.ch17 · Cited by 26
Adolescent nicotine exposure induces long-term, sex-specific disturbances in mood and anxiety-related behavioral, neuronal and molecular phenotypes in the mesocorticolimbic system
Ng, T. H. J., Sarikahya, M. H., Hudson, R., Szkudlarek, H. J., Pérez-Valenzuela, E., Uzuneser, T. C., Proud, E., Gummerson, D., Youssef, M., Machado, M., et al. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-024-01853-y · Cited by 23
Incentive salience: novel treatment strategies for major depression
Soskin, D. P., Holt, D. J., Sacco, G. R., & D, M. F. M. (2013) · CNS Spectrums · doi:10.1017/s1092852913000345 · Cited by 22
Molecular imaging as a guide for the treatment of central nervous system disorders
Kim, E., Howes, O. D., & Kapur, S. (2013) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2013.15.3/ekim · Cited by 22
Human dopamine receptor D2/D3 availability predicts amygdala reactivity to unpleasant stimuli
Kobiella, A., Vollstädt‐Klein, S., Fauth‐Bühler, M., Graf, C., Buchholz, H., Bernow, N., Yakushev, I. Y., Landvogt, C., Schreckenberger, M., Gründer, G., et al. (2009) · Human Brain Mapping · doi:10.1002/hbm.20900 · Cited by 21
Striatal Dopamine D2/3 Receptor Availability in Treatment Resistant Depression
de Kwaasteniet, B. P., Pinto, C., Ruhé, H. G., van Wingen, G. A., Booij, J., & Denys, D. A. J. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113612 · Cited by 25
Functional Neuroimaging in Geriatric Depression
Gunning, F. M., & Smith, G. S. (2011) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2011.02.010 · Cited by 24
Neuroreceptor Imaging in Psychiatry: Theory and Applications
Frankle, W. G., Slifstein, M., Talbot, P. S., & Laruelle, M. A. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)67011-0 · Cited by 19
Self-citation
Towards a multilevel model of major depression: genes, immuno-metabolic function, and cortico-striatal signaling
Paul, E. R., Östman, L., Heilig, M. A., Mayberg, H. S., & Hamilton, J. P. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02466-7 · Cited by 17
Imaging synaptic dopamine availability in individuals at clinical high-risk for psychosis: a [11C]-(+)-PHNO PET with methylphenidate challenge study
Girgis, R. R., Slifstein, M., Brucato, G., Kegeles, L. S., Colibazzi, T., Lieberman, J. A., & Abi‐Dargham, A. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00934-w · Cited by 17
Self-citation
Positron Emission Tomography Molecular Imaging in Late-Life Depression
Hirao, K., & Smith, G. S. (2014) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988713516540 · Cited by 15
Chapter IX Human forebrain dopamine systems: Characterization of the normal brain and in relation to psychiatric disorders
Hurd, Y. L., & Hall, H. (2005) · Handbook of chemical neuroanatomy · doi:10.1016/s0924-8196(05)80013-2 · Cited by 14
Postpartum Depression
Moses‐Kolko, E. L., MELTZER, C. C., Berga, S. L., & Wisner, K. L. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374285-8.00012-3 · Cited by 13
Neuroreceptor Imaging of Stress and Mood Disorders
Kennedy, S. E., & Zubieta, J.-K. (2004) · CNS Spectrums · doi:10.1017/s1092852900009238 · Cited by 12
Neuroimaging studies of bipolar depression: functional neuropathology, treatment effects, and predictors of clinical response
Ketter, T. A., & Drevets, W. C. (2002) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(02)00043-9 · Cited by 13
Molecular Imaging of Depressive Disorders
Ruhé, H. G., Visser, A. K. D., Frøkjær, V. G., Haarman, B. C. M., Klein, H. C., & Booij, J. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_5 · Cited by 11
The relation between striatal dopamine D2/D3 receptor availability and sleep quality in healthy adults
Lee, B., Chiu, N.-T., Yang, Y. K., & Chu, C. L. (2007) · Nuclear Medicine Communications · doi:10.1097/mnm.0b013e3280bad8b6 · Cited by 10
How schizophrenia and depression disrupt reward circuitry
Holcomb, H., & Rowland, L. (2007) · Current Treatment Options in Neurology · doi:10.1007/s11940-007-0021-6 · Cited by 8

Authors: Parsey, R. V., Oquendo, M. A., Zea-Ponce, Y., Rodenhiser, J., Kegeles, L. S., Pratap, M., Cooper, T. B., Van Heertum, R., Mann, J. J., & Laruelle, M.
Affiliations: Columbia University (US)
New York State Psychiatric Institute (US)
Columbia University Irving Medical Center (US)
Corresponding author: Parsey, Ramin V
ORCID: Parsey, Ramin V
Kegeles, Lawrence S
Cooper, Thomas B
Mann, J.John
Venue: Biological Psychiatry
Publisher: Elsevier BV
Published: 2001-09
Volume: 50
Issue: 5
Pages: 313-322
ISSN: 0006-3223 (ISSN-L)
DOI: 10.1016/s0006-3223(01)01089-7
OpenAlex: W1976435745
Cited by: 133
References: 50
Citations by year: 2026: 1 · 2025: 3 · 2024: 1 · 2023: 2 · 2021: 2 · 2020: 4 · 2019: 2 · 2018: 6 · 2017: 3 · 2016: 3 · 2015: 4 · 2014: 5 · 2013: 5 · 2012: 9
FWCI: 2.94
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Biological Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute of Mental Health (1K02 MH01603-01, P30MH046745, 2 P30 MH46745-10, K02MH001603)
National Center for Research Resources (M01RR000645)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
Keywords: amphetamine-induced dopamine release, major depressive disorder, striatum, [123I]IBZM, dopamine transporter imaging, dopamine signaling
MeSH terms: Adolescent, Adult, Amphetamine, Benzamides, Corpus Striatum, Major Depressive Disorder, Dopamine, Female, Humans, Iodine Radioisotopes, Male, Middle Aged, Synaptic Transmission, Pyrrolidines, Tomography, Emission-Computed, Single-Photon, Receptors, Dopamine D2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Dopamine D2 receptor availability and amphetamine-induced dopamine release in unipolar depression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks